ÏÏÏÎ¹Î±ÏÏÎ¹ÎºÎ· - ÎÎÎ¤Î ÎÎ±ÏÏÎ¹ÎºÎÏ ÎÎºÎ´ÏÏÎµÎ¹Ï

More documents

Recommendations

Info

330 B.J. HAVAKI-KONTAXAKI et al PSYCHIATRIKI 21 (4), 201033. Reiter RJ, Tan DX, Terron MP, Flores LJ, Czarnocki Z.Melatonin and its metabolites: new findings regardingtheir production and their radical scavenging actions.Acta Biochim Pol 2007, 54:1–934. Vijayalaxmi, Reiter RJ, Tan DX, Herman TS, ThomasCR. Melatonin as a radioprotective agent: a review. IntJ Radiat Oncol Biol Phys 2004, 59:639–65335. Simonneaux V, Ribelayga C. Generation of the melatoninendocrine message in mammals: A review of the complexregulation of melatonin synthesis by norepinephrine,peptides, and other pineal transmitters. Pharmacol Rev2003, 55:325–39536. Wetterberg L, Bergiannaki JD, Paparrigopoulos T,Von Knorring L, Eberhard G, Bratlid T et al. Normativemelatonin excretion: a multinational study. Psychoneuroendocrinology1999, 24:209–22637. Bergiannaki JD, Paparrigopoulos TJ, Stefanis CN.Seasonal pattern of melatonin excretion in humans:Relationship to daylength variation rate and geomagneticfield fluctuations. Experientia 1996, 52:253–25838. Carvalho LA, Gorenstein C, Moreno RA, MarkusaRP. Melatonin levels in drug-free patients withmajor depression from the southern hemisphere.Psychoneuroendocrinology 2006, 31:761–76839. Burch JB, Reif JS, Yost MG. Geomagnetic activity andhuman melatonin metabolite excretion. Neurosci Lett2008, 438:76–7940. Paparrigopoulos T, Melissaki A, Tsekou H, Efthymiou A,Kribeni G, Baziotis N et al. Melatonin secretion after headinjury: A pilot study. Brain Inj 2006, 20:873–87841. Mann JJ, Brendt DA, Arango V. The neurobiology andgenetics of suicide and attempted suicide: A focus onthe serotonergic system. Neuropsychopharmacology2001, 24:467–47642. Bergiannaki JD, Soldatos CR, Paparigopoulos TJ,Syrengelas M, Stefanis CN. Low and high melatoninexcretors among healthy individuals. J Pineal Res 1995,18:159–16443. Fountoulakis KN, Karamouzis M, Iacovides A, NimatoudisJ, Diakogiannis J, Kaprinis G et al. Morning and eveningplasma melatonin and dexamethasone suppressiontest in patients with nonseasonal major depressivedisorder from northern Greece (latitude 40–41,5o).Neuropsychobiology 2001, 44:113–11744. Papadimitriou GN, Linkowski P, Delarbre C, Mendlewicz J.Suicide on the paternal and maternal sides of depressedpatients with a lifetime history of attempted suicide. ActaPsychiatr Scand 1991, 83:417–41945. Dikeos DG, Papadimitriou GN, Soldatos CR. Familialaggregation of suicidal ideation in psychiatric patients:influence of gender. Neuropsychobiology 2004, 50:216–22046. Courtet P, Jollant F, Castelnau D, Buresi C, Malafosse A.Suicidal behavior: Relationship between phenotype andserotonergic genotype. Am J Med Genet 2005, 133C:25–3347. Mann JJ, Huang YY, Underwood MD, Kassir SA,Oppenheim S, Kelly TM et al. A serotonin transportergene promoter polymorphism (5-HTTLPR) and prefrontalcortical binding in major depression and suicide. ArchGen Psychiatry 2000, 57:729–73848. Han L, Nielsen DA, Rosenthal NE, Jefferson K, KayeW, Murphy D et al. No coding variant of the tryptophanhydroxylase gene detected in seasonal affective disorder,obsessive-compulsive disorder, anorexia nervosa, andalcoholism. Biol Psychiatry 1999, 45:615–61949. Stockmeier CA. Neurobiology of serotonin in depressionand suicide. Ann N Y Acad Sci 1997, 836:220–23250. Arango V, Huang YY, Underwood MD. Genetics of theserotonergic system in suicidal behavior. J Psychiatr Res2003, 37:375–38651. Carballo JJ, Akamnonu CP, Oquendo MA. Neurobiologyof suicidal behavior. An integration of biological and clinicalfindings. Arch Suicide Res 2008, 12:93–11052. Maes M, Scharpe S, Verkerk R, D’ Hondt P, Peeters D,Cosyns P et al. Seasonal variation in plasma L- tryptophanavailability in healthy volunteers: Relationshipsto violent suicide occurrence. Arch Gen Psychiatry 1995,52:939–94653. Souery D, Van Gestel S, Massat I, Blairy S, AdolfssonR, Blackwood D et al. Tryptophan hydroxylase polymorphismand suicidality in unipolar and bipolar affective disorders:A Multicenter Association Study. Biol Psychiatry2001, 49:405–40954. Maes M, Scharpe S, Hondt P, Peeters D, Wauters A,Neels H et al. Biochemical, metabolic and immune correlatesof seasonal variation in violent suicides: a chronoepidemiologicstudy. Eur Psychiatry 1996, 11:21– 3355. Praschak-Rieder N, Willeit M, Wilson AA. Seasonal variationin human brain serotonin transporter binding. ArchGen Psychiatry 2008, 65:1072–107756. Monteleone P, Maj M. The circadian basis of mood disorders:Recent developments and treatment implications.Eur Neuropsychopharmacology 2008, 18:701–71157. Papadopoulos FC, Frangakis CE, Skalkidou A. Exploringlag and duration effect of sunshine in triggering suicide.J Affect Disord 2005, 88:287–29758. Petridou E, Papadopoulos FC, Frangakis CE. A role ofsunshine in the triggering of suicide. Epidemiology 2002,13:106–10959. Beck-Friis J, Kjellman BF, Aperia F. Serum melatonin inrelation to clinical variables in patients with major depressivedisorder and a hypothesis of a low melatonin syndrome.Acta Psychiatr Scand 1985, 71:319–33060. Wehr TA. Photoperiodism in humans and other primates:evidence and implications. J Biol Rhythms 2001,16:348–36461. Thorne HC, Jones KH, Peters SP. Daily and seasonalvariation in the spectral composition of light exposure inhumans. Chronobiol Int 2009, 26:854–866
PSYCHIATRIKI 21 (4), 2010 SEASONALITY, SUICIDALITY AND MELATONIN 33162. Souetre E, Salvati E, Belugou JL, Douillet P, BracciniT, Dargouer G. Seasonality of suicides: environmental,sociological and biological covariations. J Affect Disord1987, 13:215–22563. Wehr TA. Melatonin and seasonal rhythms. J Biol Rhythms1997, 12:707–70864. Arendt J, Wirz-Justice, Bradtke J. Annual rhythm of serummelatonin in man. Neurosci Lett 1977, 7:327–33065. Brewerton TD. Seasonal variation of serotonin functionin humans: Research and clinical implications. Ann ClinPsychiatry 1989, 1:153–16466. Carman JS, Post RM, Buswell R, Goodwin FK.Negativeeffects of melatonin on depression. Am J Psychiatry 1976,131:1181–118667. Anton-Ray F, Chou C, Anton S et al. Brain serotoninconcentration: Elevation following intraperitoneal administrationof melatonin. Science 1986, 162:277–27868. Vermes I. Dull G, Telegdy G, Lissak K. Possible role ofserotonin in the monoamine- induced inhibition of thestress mechanism in the rat. Acta Physiol Acad ScientHungar 1972, 42:219–22369. Kevan SM. Perspectives on season of suicide: a review.Soc Sci Med 1980, 14:369–37870. Paparrigopoulos T, Kontoangelos K. Melatonin and mentaldisorders. Psyschiatriki 2003, 14:287–302Corresponding author: B.J. Havaki-Kontaxaki, Ast. Professor ofPsychiatry, 74 Vas. Sophias Ave., GR-115 28 Athens, GreeceΤel.: +30 210-72 89 257e-mail: bikont@med.uoa.gr
Page 5:
PSYCHIATRIKIQuarterly journal publi
Page 9 and 10:
PSYCHIATRIKI 21 (4), 2010 277Άρθ
Page 11 and 12: PSYCHIATRIKI 21 (4), 2010 279Resear
Page 13 and 14: PSYCHIATRIKI 21 (4), 2010 HOSPITAL
Page 19 and 20: PSYCHIATRIKI 21 (4), 2010 287Resear
Page 22 and 23: 290 P. TZOURAMANIS et al PSYCHIATRI
Page 24 and 25: 292 P. TZOURAMANIS et al PSYCHIATRI
Page 26 and 27: 294 PSYCHIATRIKI 21 (4), 2010Resear
Page 28 and 29: 296 M. VLASSOPOULOS et al PSYCHIATR
Page 36 and 37: 304 PSYCHIATRIKI 21 (4), 2010Resear
Page 38 and 39: 306 H. LAZARATOU et al PSYCHIATRIKI
Page 48 and 49: 316 C. Kouimtsidis PSYCHIATRIKI 21
Page 56 and 57: 324 PSYCHIATRIKI 21 (4), 2010Specia
Page 58 and 59: 326 B.J. HAVAKI-KONTAXAKI et al PSY
Page 60 and 61: 328 B.J. HAVAKI-KONTAXAKI et al PSY
Page 64 and 65: 332 PSYCHIATRIKI 21 (4), 2010Genera
Page 66 and 67: 334 C.I. Istokoglou et al PSYCHIATR
Page 72 and 73: 340 PSYCHIATRIKI 21 (4), 2010• 10
Page 74 and 75: SUBMISSIONPapers either in English
Page 76 and 77: ΥΠΟΒΟΛΗ ΕΡΓΑΣΙΩΝΟι
Page 78: ΣΥΝΟΔΕΥΤΙΚΟ ΕΝΤΥΠΟ
show all

ÏÏ ÏÎ¹Î±ÏÏÎ¹ÎºÎ· - ÎÎÎ¤Î ÎÎ±ÏÏÎ¹ÎºÎ­Ï ÎÎºÎ´ÏÏÎµÎ¹Ï

Create successful ePaper yourself

Delete template?

Save as template?

ÏÏÏÎ¹Î±ÏÏÎ¹ÎºÎ· - ÎÎÎ¤Î ÎÎ±ÏÏÎ¹ÎºÎÏ ÎÎºÎ´ÏÏÎµÎ¹Ï